Pharmacological pitfalls in inpatient lung transplant care and management of medication risks
Frontiers in Pharmacology · 29.05.2026 · 17
DOI: 10.3389/fphar.2026.1794658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.05.2026. Verfasst von Rolf Dieterich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pharmacotherapy after lung transplantation is complex and prone to drug–drug interactions, dosing errors, and toxicity. We retrospectively analysed 259 comments from weekly interdisciplinary rounds at the University Hospital Zurich between September 2022 and April 2024 to identify common pharmacological pitfalls in inpatient lung transplant recipients. The cohort included 62 patients (mean age 56.1 years; 40.3% female). Most comments concerned potential risks rather than confirmed harm: 54.4% were classified as potential side effects and 21.6% as potential loss of effectiveness. Interactions were the most frequent subcategory (45.6%), followed by dosage problems (14.3%). Tacrolimus was the most commonly commented on drug, often due to interactions with metamizole/dipyrone, resulting in fluctuating tacrolimus levels. Other frequent issues included QTc-prolonging combinations (e.g., domperidone with escitalopram or amiodarone in addition to itraconazole) and reduced levothyroxine absorption due to divalent cations. Only five comments reflected actual adverse outcomes, indicating overall high drug safety. These findings are consistent with the literature describing the importance of systematic pharmacological review and interdisciplinary collaboration to improve medication safety and standardise care in lung transplant recipients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland.
- Faculty of Medicine, University of Zurich, Zurich, Switzerland.
- Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
Zitieren
APA
Dieterich, R., Hage, R., Schuurmans, M. M., & Bonzon, J. (2026). Pharmacological pitfalls in inpatient lung transplant care and management of medication risks. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1794658
Vancouver
Dieterich R, Hage R, Schuurmans MM, Bonzon J. Pharmacological pitfalls in inpatient lung transplant care and management of medication risks. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1794658
BibTeX
@article{Dieterich2026,
author = {Dieterich, Rolf and Hage, René and Schuurmans, Macé M and Bonzon, Jérôme},
title = {Pharmacological pitfalls in inpatient lung transplant care and management of medication risks},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1794658}
}
EUVIMED